ArticleDigestive diseases and sciences2026
Frequent Use of Restricted Oral Intake During Hospitalization for IBD Flares Was Not Associated with Improved Clinical Outcomes: A Multicenter Retrospective Cohort Study.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are limited indications for bowel rest in hospitalized patients with inflammatory bowel disease (IBD) flares, particularly in patients with only inflammatory disease (i.e., no obstruction, abscess, or fistula). We aimed to assess the frequency of restricted oral intake and its impact on IBD-related outcomes.
methodsPatients hospitalized with flares between 2015 and 2020 in a large urban multi-hospital network were included. Patients with obstruction, active intra-abdominal abscess or fistula, elective surgery, or new IBD diagnoses were excluded. Restricted oral intake, defined as time spent nil per os (NPO) or on a clear liquid diet (CLD), was calculated as a proportion of total hospital stay and analyzed by quartiles.
resultsA total of 315 patients (137 CD, 174 UC, 4 IBDU) were included. Most patients (90.1%) had at least one period of restricted oral intake, accounting for a mean of 35.4% of hospitalization. There were no significant differences across quartiles in 30-day or 90-day readmission, unplanned surgery, or inpatient biologic use. Similar findings were observed in subgroup analyses of Crohn's disease and ulcerative colitis.
conclusionRestricted oral intake is common among hospitalized patients with IBD flares and accounts for a substantial proportion of hospitalization time. Increased duration of restricted oral intake was not associated with improved clinical outcomes. These findings support current guideline recommendations that routine dietary restriction in the absence of clear indications should be reconsidered.
Indexed as
Identifiers
42758386What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.